Published in Mediators Inflamm on January 01, 1994
Decreased expression of CD200R3 on mouse basophils as a novel marker for IgG1-mediated anaphylaxis. Immun Inflamm Dis (2015) 0.75
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest (1989) 10.59
Secretory products of macrophages. J Clin Invest (1987) 10.33
Production of hybridoma growth factor by human monocytes. Eur J Immunol (1987) 7.99
Determination of cell viability. Proc Soc Exp Biol Med (1958) 5.86
Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest (1988) 4.76
An improved colorimetric assay for interleukin 2. J Immunol Methods (1986) 3.39
Fever: role of pyrogens and cryogens. Physiol Rev (1991) 3.13
Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol (1986) 2.68
Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J Immunol (1987) 2.59
Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. J Immunol (1992) 2.29
Simple, sensitive and specific bioassay of interleukin-1. J Immunol Methods (1989) 2.18
Multiple biological activities of human recombinant interleukin 1. J Clin Invest (1986) 2.16
IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol (1991) 2.03
Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery (1988) 1.98
Thermal biology of the laboratory rat. Physiol Behav (1990) 1.85
A growth-factor dependent B-cell hybridoma. Curr Top Microbiol Immunol (1986) 1.79
Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms. Agents Actions (1990) 1.71
Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology (1988) 1.66
Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes. Immunology (1989) 1.60
In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Kinetics of dexamethasone-induced suppression. Lab Invest (1989) 1.60
Studies on the pathogenesis of fever. 18. Activation of leukocytes for pyrogen production. J Exp Med (1970) 1.49
Blockade by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity. Agents Actions (1985) 1.45
Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood (1992) 1.36
Occurrence of interleukin-1 in cerebrospinal fluid of the conscious cat. Brain Res (1988) 1.14
Relationships between local inflammation, interleukin-6 concentration and the acute phase protein response in arthritis patients. Eur J Clin Invest (1991) 1.13
Neutrophil migration induced by inflammatory stimuli is reduced by macrophage depletion. Agents Actions (1988) 1.13
The release of a neutrophil chemotactic factor from peritoneal macrophages by endotoxin: inhibition by glucocorticoids. Eur J Pharmacol (1986) 1.12
Reduction of serum Interleukin-1-like activity after treatment with dexamethasone. J Leukoc Biol (1985) 1.09
In vivo evidence that the rise in plasma IL 6 following injection of a fever-inducing dose of LPS is mediated by IL 1 beta. Cytokine (1990) 1.07
IL-1 secretion by macrophages. Enhancement of IL-1 secretion and processing by calcium ionophores. J Immunol (1990) 1.04
Tumor necrosis factor can induce fever in rats without activating protein breakdown in muscle or lipolysis in adipose tissue. J Clin Invest (1988) 1.02
Kinetics of systemic and intrahypothalamic IL-6 and tumor necrosis factor during endotoxin fever in guinea pigs. Am J Physiol (1993) 0.96
Macrophage inflammatory protein-1: unique action on the hypothalamus to evoke fever. Brain Res Bull (1990) 0.94
Antiserum against tumor necrosis factor enhances lipopolysaccharide fever in rats. Am J Physiol (1990) 0.93
The biological activity in vivo of recombinant murine interleukin 1 in the rat. Proc Soc Exp Biol Med (1986) 0.89
Antibody to tumor necrosis factor (TNF) reduces endotoxin fever. Experientia (1988) 0.88
Mechanisms of the pyrogenic actions of cytokines. Eur Cytokine Netw (1991) 0.87
Macrophages stimulated with lipopolysaccharide release a selective neutrophil chemotactic factor: an in vivo demonstration. Braz J Med Biol Res (1986) 0.85
Antiserum against tumor necrosis factor increases stress hyperthermia in rats. Am J Physiol (1990) 0.83
Neuromodulation of fever: apparent involvement of opioids. Brain Res Bull (1991) 0.82
Central effects of TNF alpha on thermogenesis and fever in the rat. Biosci Rep (1988) 0.82
Temperature and metabolic changes in rats after various doses of tumour necrosis factor alpha. J Physiol (1989) 0.80
Central actions of interleukin-8 in the rat are independent of prostaglandins. Horm Metab Res (1990) 0.79
Endogenous pyrogen formation by human blood monocytes stimulated by polyriboinosinic acid:polyribocytidylic acid. Experientia (1993) 0.78
Anti-TNF-alpha antibodies normalized body temperature and enhanced food intake in tumor-bearing rats. Am J Physiol (1993) 0.78
The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev (1988) 5.02
1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol (2001) 4.06
CD4+ cells proliferate after peanut-extract-specific and CD8+ cells proliferate after polyclonal stimulation of PBMC of children with atopic dermatitis. Clin Exp Allergy (1998) 1.46
Vbeta8+ T lymphocytes are essential in the regulation of airway hyperresponsiveness and bronchoalveolar eosinophilia but not in allergen-specific IgE in a murine model of allergic asthma. Clin Exp Allergy (1998) 1.43
Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration. Am J Respir Cell Mol Biol (1997) 1.43
Antibody formation in mouse bone marrow. IV. The influence of splenectomy on the bone marrow plaque-forming cell response to sheep red blood cells. Cell Immunol (1975) 1.42
Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis (1993) 1.39
In vivo kinetics and characterization of IFN-gamma-producing cells during a thymus-independent immune response. J Immunol (1991) 1.27
Antibody formation in mouse bone marrow. IX. Peripheral lymphoid organs are involved in the initiation of bone marrow antibody formation. Cell Immunol (1977) 1.20
Bronchoconstriction and airway hyperresponsiveness after ovalbumin inhalation in sensitized mice. Eur J Pharmacol (1995) 1.12
Selective development of a strong Th2 cytokine profile in high-risk children who develop atopy: risk factors and regulatory role of IFN-gamma, IL-4 and IL-10. Clin Exp Allergy (2001) 1.10
Regulation of antigen-specific IgE, IgG1, and mast cell responses to ingested allergen by mucosal tolerance induction. J Immunol (1997) 1.08
[Animal disease management ridicules Darwin]. Tijdschr Diergeneeskd (2004) 1.07
The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J Infect Dis (1996) 1.06
Intrathecal production of interleukin-12 and gamma interferon in patients with bacterial meningitis. Infect Immun (1997) 1.03
IgE and mast cell response on intestinal allergen exposure: a murine model to study the onset of food allergy. J Allergy Clin Immunol (1997) 1.03
Distinctions between critical illness polyneuropathy and axonal Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (2000) 1.00
Regulation of helper T cell responses to staphylococcal superantigens. Eur Cytokine Netw (2001) 0.99
Two separate genes regulate self-Ia and carrier recognition in H-2-restricted helper factors secreted by hybridoma cells. J Exp Med (1981) 0.99
Regulation of the "spontaneous' (background) immunoglobulin synthesis. Int Arch Allergy Appl Immunol (1981) 0.96
Immunoglobulin isotype expression. II. Frequency analysis in mitogen-reactive B cells. Eur J Immunol (1981) 0.96
Interleukin-10 and soluble tumor necrosis factor receptors in cerebrospinal fluid of children with bacterial meningitis. J Infect Dis (1996) 0.94
Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue. J Neuroimmunol (2000) 0.93
A mouse model to study immunity against pseudorabies virus infection: significance of CD4+ and CD8+ cells in protective immunity. Vaccine (1998) 0.93
Allergen immunotherapy inhibits airway eosinophilia and hyperresponsiveness associated with decreased IL-4 production by lymphocytes in a murine model of allergic asthma. Am J Respir Cell Mol Biol (1998) 0.93
Tumour necrosis factor, but not interferon-gamma, is essential for acquired resistance to Listeria monocytogenes during a secondary infection in mice. Immunology (1995) 0.92
The capacity and mechanism of bone marrow antibody formation by thymus-independent antigens. J Immunol (1982) 0.91
Pathogenesis of skin lesions in mice with chronic proliferative dermatitis (cpdm/cpdm). Am J Pathol (1996) 0.91
Fc receptor binding of anti-CD3 monoclonal antibodies is not essential for immunosuppression, but triggers cytokine-related side effects. Eur J Immunol (1995) 0.90
Cytokine regulation of immunoglobulin isotype switching and expression. Semin Immunol (1989) 0.90
T cells subsets and cytokines in allergic and non-allergic children. II. Analysis and IL-5 and IL-10 mRNA expression and protein production. Cytokine (1997) 0.89
Regulation of delayed type hypersensitivity to host histocompatibility antigens during graft-versus-host reactions. Immunol Rev (1985) 0.89
T cell subsets and cytokines in allergic and non-allergic children. I. Analysis of IL-4, IFN-gamma and IL-13 mRNA expression and protein production. Cytokine (1997) 0.88
Construction of human-mouse T cell hybrids that express human T cell-associated surface antigens and allow the chromosomal localization of these antigens. J Immunol (1986) 0.87
Suppression of polyclonal and antigen-specific murine IgG1 but not IgE responses by neutralizing interleukin-6 in vivo. Eur J Immunol (1994) 0.87
Corticosteroids and the humoral immune response of mice. II. Enhancement of bone marrow antibody formation to lipopolysaccharide by high doses of corticosteroids. Cell Immunol (1979) 0.87
Corticosteroids and the humoral immune response of mice i. Differential effect of corticosteroids upon antibody formation to sheep red blood cells in spleen and bone marrow. Cell Immunol (1978) 0.87
Markers for early sensitization and inflammation in relation to clinical manifestations of atopic disease up to 2 years of age in 133 high-risk children. Clin Exp Allergy (2000) 0.86
Complement split product C5a mediates the lipopolysaccharide-induced mobilization of CFU-s and haemopoietic progenitor cells, but not the mobilization induced by proteolytic enzymes. Cell Tissue Kinet (1986) 0.86
Toxocara-induced eosinophilic inflammation. Airway function and effect of anti-IL-5. Am J Respir Crit Care Med (1995) 0.86
Deficient antibody formation in the bone marrow of nude mice. Immunology (1978) 0.85
Modulation of systemic cytokine levels by implantation of alginate encapsulated cells. J Immunol Methods (1994) 0.85
Comparative spectra analysis (CoSA): spectra as three-dimensional molecular descriptors for the prediction of biological activities. J Chem Inf Comput Sci (1999) 0.83
Cytokine antagonists and their potential therapeutic use. Immunol Today (1994) 0.83
Secondary IgE responses in vivo are predominantly generated via gamma 1 epsilon-double positive B cells. Scand J Immunol (1994) 0.83
Antibody to interleukin-5 inhibits virus-induced airway hyperresponsiveness to histamine in guinea pigs. Am J Respir Crit Care Med (1995) 0.83
Interleukin 4 receptors on human bronchial epithelial cells. An in vivo and in vitro analysis of expression and function. Cytokine (1998) 0.82
T-lymphocyte subpopulations in patients with various courses after hepatitis B virus infection. Scand J Gastroenterol (1984) 0.82
UV exposure alters respiratory allergic responses in mice. Photochem Photobiol (2000) 0.82
Differential ultraviolet-B-induced immunomodulation in XPA, XPC, and CSB DNA repair-deficient mice. J Invest Dermatol (2001) 0.81
Prolonged in vivo IL-4 treatment inhibits antigen-specific IgG1 and IgE formation. Scand J Immunol (1994) 0.81
Activation and re-activation potential of T cells responding to staphylococcal enterotoxin B. Int Immunol (1995) 0.81
Inhibition of diabetes in NOD mice by human pregnancy factor. Hum Immunol (2001) 0.80
Recombinant interleukin-5 induces in vivo airway hyperresponsiveness to histamine in guinea pigs. Eur J Pharmacol (1993) 0.80
Clinico-immunological heterogeneity in Comèl-Netherton syndrome. Dermatology (2001) 0.79
Differential effectiveness of anti-CD8 treatment on ongoing graft-versus-host reactions in mice. Transpl Immunol (1996) 0.79
Soluble E-selectin, other markers of inflammation and disease severity in children with atopic dermatitis. Br J Dermatol (1998) 0.79
Cytokines in the muscle tissue of idiopathic inflammatory myopathies: implications for immunopathogenesis and therapy. Eur Cytokine Netw (1999) 0.79
Antibody formation in mouse bone marrow. VII. Evidence against the migration of plaque-forming cells as the underlying cause for bone marrow plaque-forming cell activity: a study with parabiotic mice. Cell Immunol (1977) 0.79
Correction of the X-linked immunodeficiency phenotype by transgenic expression of human Bruton tyrosine kinase under the control of the class II major histocompatibility complex Ea locus control region. Proc Natl Acad Sci U S A (1997) 0.79
Cellular and humoral immunity in patients with hyperthyroid Graves' disease before, during and after antithyroid drug treatment. Clin Endocrinol (Oxf) (1987) 0.79
The effect of corticosteroids upon the number and organ distribution of "background" immunoglobulin-secreting cells in mice. Cell Immunol (1983) 0.79
Involvement of T cells in enhanced resistance to Klebsiella pneumoniae septicemia in mice treated with liposome-encapsulated muramyl tripeptide phosphatidylethanolamine or gamma interferon. Infect Immun (1998) 0.79
Modulation of total IgE levels in serum of normal and athymic nude BALB/c mice by T cells and exogenous antigenic stimulation. Int Arch Allergy Appl Immunol (1989) 0.79
Analysis of cyt0kine gene expression in stimulated T cells of small children by semi-quantitative PCR. Mediators Inflamm (1995) 0.78
Increased adjuvant efficacy in stimulation of antibody responses after macrophage elimination in vivo. Immunology (1997) 0.78
Leukocyte mobilization in mice by polyanions. Decline of leukocyte mobilizing capacity after transplantation of lymphoma. Cell Tissue Kinet (1981) 0.77
Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed to T cells or their subsets. II. Differential effectiveness of IgG2a and IgG2b isotypes of anti-CD3 and anti-CD4 moAb. Bone Marrow Transplant (1994) 0.77
Levels of soluble intercellular adhesion molecule-1, soluble E-selectin, tumor necrosis factor-alpha, and soluble tumor necrosis factor receptor p55 and p75 in atopic children. Allergy (1998) 0.77
Serum immunoglobulin levels in mice. Determination of the low IgA level in AKR mice by an irradiation-resistant factor. Int Arch Allergy Appl Immunol (1979) 0.76
The X-linked immunodeficiency defect in the mouse is corrected by expression of human Bruton's tyrosine kinase from a yeast artificial chromosome transgene. Eur J Immunol (1997) 0.76
Development of immune functions related to allergic mechanisms in young children. Pediatr Res (1996) 0.76
The role of cytokines in ultraviolet-B induced immunosuppression. Eur Cytokine Netw (1997) 0.76
UVB irradiation modulates systemic immune responses by affecting cytokine production of antigen-presenting cells. Int Immunol (2000) 0.76
Cytokine Detection and Modulation in Acute Graft vs. Host Disease in Mice. Mediators Inflamm (1994) 0.75
Cytokines as cellular communicators. Mediators Inflamm (1996) 0.75
Interleukin 5 as a drug target in allergy and asthma. Trends Pharmacol Sci (1995) 0.75
Cytokines in clinical and experimental transplantation. Mediators Inflamm (1994) 0.75
Immunotherapy with monoclonal antibodies directed against the immunosuppressive domain of p15E inhibits tumour growth. Clin Exp Immunol (1995) 0.75
B memory cells in the thymus: part of the pool of potentially circulating memory cells. J Immunol (1977) 0.75
Lipopolysaccharide-induced suppression of graft-versus-host reactivity in mice. Immunobiology (1988) 0.75
Terasaki-ELISA for murine IgE. III. Determination of concentration and functional affinity by sequential equilibrium binding analysis. J Immunol Methods (1989) 0.75
Suppression of skin allograft rejection in mice by anti-CD3 monoclonal antibodies without cytokine-related side-effects. Transplantation (1994) 0.75
Induction and suppression of graft-versus-host reactivity in B6.C-H-2 mutant mice. Transplant Proc (1987) 0.75
Quantitative aspects of the nonspecific humoral immune response to sheep erythrocytes. Adv Exp Med Biol (1982) 0.75
A rat anti-mouse CD3 monoclonal antibody induces long-term skin allograft survival without inducing side effects. Transplant Proc (1994) 0.75
Regulation of IgE production in mice. Eur Respir J Suppl (1991) 0.75
Cytokines in lethal graft-versus-host disease. Transpl Int (1992) 0.75
Suppression of graft-versus-host reactivity by a single host-specific blood transfusion to prospective donors of hemopoietic cells. Transplantation (1991) 0.75
Role of the immune system in allergic children. Pediatr Allergy Immunol (1995) 0.75
Quantitation of murine IgE in an automatic ELISA system. Adv Exp Med Biol (1985) 0.75